✦ LIBER ✦

A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule

✍ Scribed by H. Kunikane; Y. Kurita; K. Watanabe; A. Yokoyama; K. Noda; Y. Fujita; S. Yoneda; Y. Nakai; H. Niitani

Publisher: Springer
Year: 2001
Tongue: English
Weight: 48 KB
Volume: 6
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-001-8029-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of the paclitaxel–cisplatin

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Paclitaxel and gemcitabine combination i

Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase i study

✍ Athanasios Athanasiadis; George Roussos; Thomas Papakostoulis; Daniela-Carmen At 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 197 KB

Biweekly regimen of cisplatin, gemcitabi

Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer

✍ Javier Castro de Carpeño; M. González Barón; J. Aguiar; J. I. Chacón; J. Feliu; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 230 KB

Phase II study of the combination of vin

Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Keigo Tominaga 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 169 KB

Combination of low-dose cisplatin and ge

Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

✍ J. Feliu; G. Martín; C. Madroñal; A. Rodríguez-Jaráiz; J. Castro; A Rodríguez; T 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB

Prolonged gemcitabine infusion in advanc

Prolonged gemcitabine infusion in advanced non–small cell lung carcinoma : A randomized Phase II study of two different schedules in combination with cisplatin

✍ Anna Ceribelli; Cesare Gridelli; Filippo De Marinis; Alessandra Fabi; Teresa Gam 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND Preclinical and clinical evidence suggests that a fixed infusion rate of 10 mg/m^2^ per minute may be more effective than the standard 30‐minute infusion of gemcitabine. To investigate the activity and toxicity of the cisplatin plus gemcitabine combination with gemcitabin